These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23618525)

  • 1. Current medical and surgical management of Raynaud's syndrome.
    Landry GJ
    J Vasc Surg; 2013 Jun; 57(6):1710-6. PubMed ID: 23618525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing Raynaud's phenomenon: a practical approach.
    Adee AC
    Am Fam Physician; 1993 Mar; 47(4):823-9. PubMed ID: 8438681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Video-thoracoscopic sympathectomy in the treatment of Raynaud's disease and palmar hyperhidrosis].
    Trignano M; Boatto R; Mastino GP; Ferrandu T; Padula G; Loi V; Pala C
    Minerva Chir; 2000; 55(1-2):17-23. PubMed ID: 10832279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raynaud's syndrome: diagnosis and treatment.
    Whitaker L; Kelleher A
    J Vasc Nurs; 1994 Mar; 12(1):10-3. PubMed ID: 7748770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the treatment of Raynaud's phenomenon.
    Levien TL
    Vasc Health Risk Manag; 2010 Mar; 6():167-77. PubMed ID: 20448801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The therapy of Raynaud's phenomenon].
    Di Giacinto G
    Clin Ter; 1993 Feb; 142(2):161-74. PubMed ID: 8472530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's Syndrome: a neglected disease.
    Poredos P; Poredos P
    Int Angiol; 2016 Apr; 35(2):117-21. PubMed ID: 25673314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing Cilostazol for Raynaud's Phenomenon.
    El-Hachem N; Fardoun MM; Slika H; Baydoun E; Eid AH
    Curr Med Chem; 2021; 28(12):2409-2417. PubMed ID: 32881655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment of peripheral vascular disease.
    Eberhardt RT; Coffman JD
    Heart Dis; 2000; 2(1):62-74. PubMed ID: 11728242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A treatment of Raynaud's phenomenon: a review.
    Iorio ML; Masden DL; Higgins JP
    Semin Arthritis Rheum; 2012 Feb; 41(4):599-603. PubMed ID: 21868066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervicothoracic sympathectomy for Raynaud's syndrome.
    Lowell RC; Gloviczki P; Cherry KJ; Bower TC; Hallett JW; Schirger A; Pairolero PC
    Int Angiol; 1993 Jun; 12(2):168-72. PubMed ID: 8370999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Raynaud's Phenomenon in the Patient with Connective Tissue Disease.
    Chatterjee S
    Curr Treat Options Cardiovasc Med; 2010 Apr; 12(2):185-204. PubMed ID: 20842555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raynaud's phenomenon: pathogenesis and management.
    Bakst R; Merola JF; Franks AG; Sanchez M
    J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of metoprolol alone and combined metoprolol-felodipin on the digital microcirculation of patients with primary Raynaud's syndrome.
    Csiki Z; Garai I; Shemirani AH; Papp G; Zsori KS; Andras C; Zeher M
    Microvasc Res; 2011 Jul; 82(1):84-7. PubMed ID: 21515290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raynaud's phenomenon.
    O'connor CM
    J Vasc Nurs; 2001 Sep; 19(3):87-92; quiz 93-4. PubMed ID: 11533581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
    Henness S; Wigley FM
    Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacology of Raynaud's phenomenon].
    Roustit M; Khouri C; Blaise S; Villier C; Carpentier P; Cracowski JL
    Therapie; 2014; 69(2):115-28. PubMed ID: 24926630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New treatments for Raynaud's syndrome].
    Bellucci S; Kedra W; Ajzenberg N; Tobelem G; Caen J
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):103-7. PubMed ID: 3290833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.